{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:46:33Z","timestamp":1782348393604,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"DOI":"10.7759\/cureus.111446","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:54:31Z","timestamp":1782345271000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Plasmablastic Myeloma With Dual Kappa and Lambda mRNA Expression Presenting as a Solitary Hard Palate Tumor"],"prefix":"10.7759","author":[{"given":"Ken","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.2.305.305","article-title":"Multiple myeloma: significance of plasmablastic subtype in morphological classification","volume":"65","author":"Greipp PR","year":"1985","unstructured":"Greipp PR, Raymond NM, Kyle RA, O\u2019Fallon WM. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood. 1985, 65:305-310. 10.1182\/blood.V65.2.305.305","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPENJ68FFBRIYB","article-title":"Plasma cell myeloma and related neoplasms","volume":"136","author":"Lorsbach RB","year":"2011","unstructured":"Lorsbach RB, Hsi ED, Dogan A, Fend F. Plasma cell myeloma and related neoplasms. Am J Clin Pathol. 2011, 136:168-182. 10.1309\/AJCPENJ68FFBRIYB","journal-title":"Am J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234436","article-title":"Aggressive presentation of plasmablastic myeloma","volume":"13","author":"Suarez-Londono JA","year":"2020","unstructured":"Suarez-Londono JA, Rohatgi A, Antoine-Pepeljugoski C, Braunstein MJ. Aggressive presentation of plasmablastic myeloma. BMJ Case Rep. 2020, 13:e234436. 10.1136\/bcr-2020-234436","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-240998","article-title":"Rare case of plasmablastic myeloma diagnosed on lung biopsy","volume":"14","author":"Ayeboa-Sallah B","year":"2021","unstructured":"Ayeboa-Sallah B, Qutab S, Grace R, Sharma N. Rare case of plasmablastic myeloma diagnosed on lung biopsy. BMJ Case Rep. 2021, 14:10.1136\/bcr-2020-240998","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13863","article-title":"Plasmablastic lymphoma: an update","volume":"44","author":"Bailly J","year":"2022","unstructured":"Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ. Plasmablastic lymphoma: an update. Int J Lab Hematol. 2022, 44:54-63. 10.1111\/ijlh.13863","journal-title":"Int J Lab Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2019.08.001","article-title":"Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature","volume":"128","author":"Bhattacharyya S","year":"2019","unstructured":"Bhattacharyya S, Bains AP, Sykes DL, Iverson BR, Sibgatullah R, Kuklani RM. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019, 128:651-659. 10.1016\/j.oooo.2019.08.001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022335","article-title":"Oral plasmablastic lymphoma: a case report","volume":"99","author":"Zizzo M","year":"2020","unstructured":"Zizzo M, Zanelli M, Martiniani R, et al.. Oral plasmablastic lymphoma: a case report. Medicine (Baltimore). 2020, 99:e22335. 10.1097\/MD.0000000000022335","journal-title":"Medicine (Baltimore)"},{"key":"ref8","article-title":"Plasma cell myeloma with dual expression of kappa and lambda light chains","volume":"11","author":"Jiang AS","year":"2018","unstructured":"Jiang AS, Wu Z, Wei EX, Ni H, You B, Yang T, Jiang JG. Plasma cell myeloma with dual expression of kappa and lambda light chains. Int J Clin Exp Pathol. 2018, 11:4718-4723.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-021-00621-8","article-title":"A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains","volume":"26","author":"Matsuoka R","year":"2021","unstructured":"Matsuoka R, Sakamoto N, Kato T, Chiba S, Noguchi M. A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains. Eur J Med Res. 2021, 26:148. 10.1186\/s40001-021-00621-8","journal-title":"Eur J Med Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000001069","article-title":"Dual expression of immunoglobulin light chains in plasma cell myeloma: a case report and literature review","volume":"31","author":"Suresh J","year":"2023","unstructured":"Suresh J, Wu Y, Sabaratnam R, Brijlall S, Kyle B, Torlakovic EE. Dual expression of immunoglobulin light chains in plasma cell myeloma: a case report and literature review. Appl Immunohistochem Mol Morphol. 2023, 31:447-451. 10.1097\/PAI.0000000000001069","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2009.00874.x","article-title":"Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?","volume":"39","author":"Boy SC","year":"2010","unstructured":"Boy SC, van Heerden MB, Raubenheimer EJ, van Heerden WF. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?. J Oral Pathol Med. 2010, 39:435-439. 10.1111\/j.1600-0714.2009.00874.x","journal-title":"J Oral Pathol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1397335","article-title":"An aggressive plasmablastic lymphoma of the oral cavity as primary manifestation of acquired immunodeficiency syndrome: case report and literature review","volume":"19","author":"Corti M","year":"2015","unstructured":"Corti M, Minu\u00e9 G, Campitelli A, Narbaitz M, Gilardi L. An aggressive plasmablastic lymphoma of the oral cavity as primary manifestation of acquired immunodeficiency syndrome: case report and literature review. Int Arch Otorhinolaryngol. 2015, 19:354-358. 10.1055\/s-0034-1397335","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2017.11.023","article-title":"Extra-skeletal plasmablastic myeloma presenting as palatal growth - An unusual entity","volume":"41","author":"Kumar S","year":"2017","unstructured":"Kumar S, Bhutani N, Bhargawa S, Kataria SP, Sen R. Extra-skeletal plasmablastic myeloma presenting as palatal growth - An unusual entity. Int J Surg Case Rep. 2017, 41:423-426. 10.1016\/j.ijscr.2017.11.023","journal-title":"Int J Surg Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-144","article-title":"Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas","volume":"9","author":"Rimsza LM","year":"2014","unstructured":"Rimsza LM, Day WA, McGinn S, et al.. Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas. Diagn Pathol. 2014, 9:144. 10.1186\/1746-1596-9-144","journal-title":"Diagn Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21629","article-title":"Branched-chain in situ hybridization for \u03ba and \u03bb light chains: a powerful ancillary technique for determining B-cell clonality in cytology samples","volume":"124","author":"Arora K","year":"2016","unstructured":"Arora K, Chebib I, Zukerberg L, Gandhi M, Rivera M, Ting D, Deshpande V. Branched-chain in situ hybridization for \u03ba and \u03bb light chains: a powerful ancillary technique for determining B-cell clonality in cytology samples. Cancer Cytopathol. 2016, 124:203-212. 10.1002\/cncy.21629","journal-title":"Cancer Cytopathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34641","article-title":"The prognostic role of 1q21 gain\/amplification in newly diagnosed multiple myeloma: The faster, the worse","volume":"129","author":"Wang Y","year":"2023","unstructured":"Wang Y, Xu J, Xu B, et al.. The prognostic role of 1q21 gain\/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer. 2023, 129:1005-1016. 10.1002\/cncr.34641","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008346","article-title":"del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma","volume":"137","author":"Corre J","year":"2021","unstructured":"Corre J, Perrot A, Caillot D, et al.. del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma. Blood. 2021, 137:1192-1195. 10.1182\/blood.2020008346","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284666","article-title":"MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities","volume":"109","author":"Liu Y","year":"2024","unstructured":"Liu Y, Lv R, Yan W, et al.. MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities. Haematologica. 2024, 109:1619-1623. 10.3324\/haematol.2023.284666","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.668099","article-title":"Multiple extramedullary-bone related and\/or extramedullary extraosseous are independent poor prognostic factors in patients with newly diagnosed multiple myeloma","volume":"11","author":"He J","year":"2021","unstructured":"He J, Yue X, He D, et al.. Multiple extramedullary-bone related and\/or extramedullary extraosseous are independent poor prognostic factors in patients with newly diagnosed multiple myeloma. Front Oncol. 2021, 11:668099. 10.3389\/fonc.2021.668099","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar SV","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024, 99:1802-1824. 10.1002\/ajh.27422","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/486163-a-rare-case-of-plasmablastic-myeloma-with-dual-kappa-and-lambda-mrna-expression-presenting-as-a-solitary-hard-palate-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:54:32Z","timestamp":1782345272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/486163-a-rare-case-of-plasmablastic-myeloma-with-dual-kappa-and-lambda-mrna-expression-presenting-as-a-solitary-hard-palate-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.111446","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}